Clinical Trials · NCT00978211
DOTA-TOC in Metastasized Neuroendocrine Tumors
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University Hospital, Basel, Switzerland
- Enrollment
- 1,499
- Start date
- Sep 1997
- Locations
- 1 site, Switzerland
- Primary endpoint
- Response